FA
AGN

FDx Advisors’s Allergan plc AGN Stock Holding History

FDx Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,811
Closed -$852K – 642
2020
Q1 		$852K Sell
4,811
-1,782
-27% -$336K 0.06% 213
2019
Q4 		$1.26M Sell
6,593
-2,015
-23% -$363K 0.07% 197
2019
Q3 		$1.45M Buy
8,608
+1,724
+25% +$281K 0.1% 167
2019
Q2 		$1.15M Sell
6,884
-224
-3% -$31K 0.05% 290
2019
Q1 		$1.04M Buy
7,108
+272
+4% +$39.4K 0.04% 285
2018
Q4 		$914K Sell
6,836
-2,604
-28% -$427K 0.08% 198
2018
Q3 		$1.8M Buy
9,440
+378
+4% +$69.4K 0.07% 219
2018
Q2 		$1.51M Sell
9,062
-2,871
-24% -$461K 0.05% 280
2018
Q1 		$2.01M Buy
11,933
+3,891
+48% +$653K 0.06% 288
2017
Q4 		$1.32M Sell
8,042
-3,102
-28% -$557K 0.04% 454
2017
Q3 		$2.28M Buy
11,144
+237
+2% +$55.1K 0.06% 277
2017
Q2 		$2.65M Buy
10,907
+965
+10% +$227K 0.08% 224
2017
Q1 		$2.38M Buy
9,942
+985
+11% +$229K 0.07% 254
2016
Q4 		$1.88M Sell
8,957
-1,815
-17% -$376K 0.05% 300
2016
Q3 		$2.48M Sell
10,772
-217
-2% -$53K 0.1% 161
2016
Q2 		$2.54M Buy
10,989
+2,855
+35% +$658K 0.11% 162
2016
Q1 		$2.18M Sell
8,134
-2,191
-21% -$627K 0.1% 184
2015
Q4 		$3.23M Sell
10,325
-2,664
-21% -$793K 0.15% 117
2015
Q3 		$3.53M Sell
12,989
-6,643
-34% -$2.04M 0.3% 60
2015
Q2 		$5.96M Sell
19,632
-3,268
-14% -$975K 0.3% 64
2015
Q1 		$6.8M Buy
22,900
+5,140
+29% +$1.47M 0.15% 126
2014
Q4 		$4.57M Sell
17,760
-480
-3% -$120K 0.28% 64
2014
Q3 		$4.4M Sell
18,240
-2,160
-11% -$483K 0.29% 60
2014
Q2 		$4.55M Buy
20,400
+4,535
+29% +$939K 0.3% 57
2014
Q1 		$3.27M Buy
15,865
+11,707
+282% +$2.32M 0.27% 71
2013
Q4 		$699K Sell
4,158
-140
-3% -$21.9K 0.07% 277
2013
Q3 		$619K Buy
4,298
+577
+16% +$76.9K 0.07% 249
2013
Q2 		$470K Buy
+3,721
New +$421K 0.06% 270

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

FDx Advisors's AGN Position: Q2 2020 in Review

FDx Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,811 shares — an estimated $852K sold.

FDx Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.8M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • FDx Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • FDx Advisors sold 4,811 Allergan plc shares in Q2 2020, an estimated $852K.
  • FDx Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • FDx Advisors's Allergan plc position peaked at $6.8M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on FDx Advisors's 13F filing for Q2 2020, filed 22 Jul 2020.